Atlas Trials

A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and Vomiting

Clinical trial NCT07709897 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07709897
Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prevention of Postoperative Nausea and Vomiting
Start date
2026-07-01
Primary completion
2026-12-01
Enrollment
260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.